Compare MOBX & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MOBX | MOVE |
|---|---|---|
| Founded | 2020 | 2018 |
| Country | United States | United States |
| Employees | 46 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6M | 15.9M |
| IPO Year | N/A | 2021 |
| Metric | MOBX | MOVE |
|---|---|---|
| Price | $1.03 | $13.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 83.0M | 42.9K |
| Earning Date | 01-01-0001 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,013,000.00 |
| Revenue This Year | N/A | $1,460.71 |
| Revenue Next Year | N/A | $96.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.51 |
| 52 Week High | $1.44 | $34.87 |
| Indicator | MOBX | MOVE |
|---|---|---|
| Relative Strength Index (RSI) | 72.79 | 52.99 |
| Support Level | $0.78 | $0.62 |
| Resistance Level | $1.44 | $21.23 |
| Average True Range (ATR) | 0.16 | 1.16 |
| MACD | 0.10 | 0.16 |
| Stochastic Oscillator | 72.49 | 54.36 |
Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. Its wireless systems solutions include products for RF and millimeter wave (mmWave) communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the defense, aerospace, commercial and industrial sectors. The majority of the company's revenue is derived from product sales to equipment manufacturers. Geographically, it generates the maximum revenue from the United States.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.